MICRON TECHNOLOGY, INC. | ||
(Exact name of registrant as specified in its charter) |
Delaware | 1-10658 | 75-1618004 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
8000 South Federal Way | ||
Boise, Idaho 83716-9632 | ||
(Address of principal executive offices and Zip Code) |
(208) 368-4000 | ||
(Registrant’s telephone number, including area code) |
Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.10 per share | MU | Nasdaq Global Select Market |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits. | ||||
(d) Exhibits. |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
MICRON TECHNOLOGY, INC. | |||||||||||
Date: | December 20, 2023 | By: | /s/ Mark Murphy | ||||||||
Name: | Mark Murphy | ||||||||||
Title: | Executive Vice President and Chief Financial Officer |
Contacts: | Satya Kumar |
Erica Rodriguez Pompen | ||||||
Investor Relations | Media Relations | |||||||
satyakumar@micron.com |
epompen@micron.com | |||||||
(408) 450-6199 |
(408) 834-1873 |
Quarterly Financial Results | |||||||||||||||||||||||
(in millions, except per share amounts) | GAAP(1) |
Non-GAAP(2) |
|||||||||||||||||||||
FQ1-24 |
FQ4-23 | FQ1-23 |
FQ1-24 | FQ4-23 | FQ1-23 | ||||||||||||||||||
Revenue | $ | 4,726 | $ | 4,010 | $ | 4,085 | $ | 4,726 | $ | 4,010 | $ | 4,085 | |||||||||||
Gross margin | (35) | (435) | 893 | 37 | (366) | 934 | |||||||||||||||||
percent of revenue | (0.7 | %) | (10.8 | %) | 21.9 | % | 0.8 | % | (9.1 | %) | 22.9 | % | |||||||||||
Operating expenses | 1,093 | 1,037 | 1,102 | 992 | 842 | 999 | |||||||||||||||||
Operating income (loss) | (1,128) | (1,472) | (209) | (955) | (1,208) | (65) | |||||||||||||||||
percent of revenue | (23.9 | %) | (36.7 | %) | (5.1 | %) | (20.2 | %) | (30.1 | %) | (1.6 | %) | |||||||||||
Net income (loss) | (1,234) | (1,430) | (195) | (1,048) | (1,177) | (39) | |||||||||||||||||
Diluted earnings (loss) per share | (1.12) | (1.31) | (0.18) | (0.95) | (1.07) | (0.04) |
FQ2-24 |
GAAP(1) Outlook |
Non-GAAP(2) Outlook |
||||||
Revenue |
$5.30 billion ± $200 million | $5.30 billion ± $200 million | ||||||
Gross margin |
12.0% ± 1.5% | 13.0% ± 1.5% | ||||||
Operating expenses |
$1.07 billion ± $15 million | $950 million ± $15 million | ||||||
Diluted earnings (loss) per share |
($0.45) ± $0.07 | ($0.28) ± $0.07 |
1st Qtr. |
4th Qtr. |
1st Qtr. |
|||||||||
November 30, 2023 |
August 31, 2023 |
December 1, 2022 |
|||||||||
Revenue | $ | 4,726 | $ | 4,010 | $ | 4,085 | |||||
Cost of goods sold | 4,761 | 4,445 | 3,192 | ||||||||
Gross margin | (35) | (435) | 893 | ||||||||
Research and development | 845 | 719 | 849 | ||||||||
Selling, general, and administrative | 263 | 219 | 251 | ||||||||
Restructure and asset impairments | — | 4 | 13 | ||||||||
Other operating (income) expense, net | (15) | 95 | (11) | ||||||||
Operating income (loss) | (1,128) | (1,472) | (209) | ||||||||
Interest income | 132 | 134 | 88 | ||||||||
Interest expense | (132) | (129) | (51) | ||||||||
Other non-operating income (expense), net | (27) | 9 | (4) | ||||||||
(1,155) | (1,458) | (176) | |||||||||
Income tax (provision) benefit | (73) | 24 | (8) | ||||||||
Equity in net income (loss) of equity method investees | (6) | 4 | (11) | ||||||||
Net income (loss) | $ | (1,234) | $ | (1,430) | $ | (195) | |||||
Earnings (loss) per share | |||||||||||
Basic | $ | (1.12) | $ | (1.31) | $ | (0.18) | |||||
Diluted | (1.12) | (1.31) | (0.18) | ||||||||
Number of shares used in per share calculations | |||||||||||
Basic | 1,100 | 1,095 | 1,090 | ||||||||
Diluted | 1,100 | 1,095 | 1,090 |
As of | November 30, 2023 |
August 31, 2023 |
||||||
Assets | ||||||||
Cash and equivalents | $ | 8,075 | $ | 8,577 | ||||
Short-term investments | 973 | 1,017 | ||||||
Receivables | 2,943 | 2,443 | ||||||
Inventories | 8,276 | 8,387 | ||||||
Other current assets | 791 | 820 | ||||||
Total current assets | 21,058 | 21,244 | ||||||
Long-term marketable investments | 720 | 844 | ||||||
Property, plant, and equipment | 37,677 | 37,928 | ||||||
Operating lease right-of-use assets | 648 | 666 | ||||||
Intangible assets | 416 | 404 | ||||||
Deferred tax assets | 781 | 756 | ||||||
Goodwill | 1,150 | 1,150 | ||||||
Other noncurrent assets | 1,326 | 1,262 | ||||||
Total assets | $ | 63,776 | $ | 64,254 | ||||
Liabilities and equity | ||||||||
Accounts payable and accrued expenses | $ | 3,946 | $ | 3,958 | ||||
Current debt | 908 | 278 | ||||||
Other current liabilities | 1,108 | 529 | ||||||
Total current liabilities | 5,962 | 4,765 | ||||||
Long-term debt | 12,597 | 13,052 | ||||||
Noncurrent operating lease liabilities | 601 | 603 | ||||||
Noncurrent unearned government incentives | 705 | 727 | ||||||
Other noncurrent liabilities | 1,026 | 987 | ||||||
Total liabilities | 20,891 | 20,134 | ||||||
Commitments and contingencies | ||||||||
Shareholders’ equity | ||||||||
Common stock | 124 | 124 | ||||||
Additional capital | 11,217 | 11,036 | ||||||
Retained earnings | 39,356 | 40,824 | ||||||
Treasury stock | (7,552) | (7,552) | ||||||
Accumulated other comprehensive income (loss) | (260) | (312) | ||||||
Total equity | 42,885 | 44,120 | ||||||
Total liabilities and equity | $ | 63,776 | $ | 64,254 | ||||
Three months ended | November 30, 2023 |
December 1, 2022 |
||||||
Cash flows from operating activities | ||||||||
Net income (loss) | $ | (1,234) | $ | (195) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Depreciation expense and amortization of intangible assets | 1,915 | 1,921 | ||||||
Stock-based compensation | 188 | 146 | ||||||
Change in operating assets and liabilities: |
||||||||
Receivables | (501) | 1,842 | ||||||
Inventories | 111 | (1,697) | ||||||
Accounts payable and accrued expenses | 271 | (630) | ||||||
Other current liabilities |
579 | (430) | ||||||
Other | 72 | (14) | ||||||
Net cash provided by operating activities | 1,401 | 943 | ||||||
Cash flows from investing activities | ||||||||
Expenditures for property, plant, and equipment | (1,796) | (2,449) | ||||||
Purchases of available-for-sale securities | (199) | (90) | ||||||
Proceeds from maturities and sales of available-for-sale securities |
374 | 362 | ||||||
Proceeds from government incentives | 85 | 2 | ||||||
Other | (22) | (91) | ||||||
Net cash provided by (used for) investing activities | (1,558) | (2,266) | ||||||
Cash flows from financing activities | ||||||||
Payments of dividends to shareholders | (129) | (126) | ||||||
Payments on equipment purchase contracts | (56) | (47) | ||||||
Repayments of debt | (53) | (20) | ||||||
Repurchases of common stock - repurchase program | — | (425) | ||||||
Proceeds from issuance of debt | — | 3,349 | ||||||
Other | (114) | (99) | ||||||
Net cash provided by (used for) financing activities | (352) | 2,632 | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash |
(1) | (6) | ||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | (510) | 1,303 | ||||||
Cash, cash equivalents, and restricted cash at beginning of period | 8,656 | 8,339 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 8,146 | $ | 9,642 |
1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
November 30, 2023 |
August 31, 2023 |
December 1, 2022 |
|||||||||
Provision to write down inventory to NRV | $ | — | $ | — | $ | — | |||||
Lower costs from sale of inventory written down in prior periods | 605 | 563 | — | ||||||||
$ | 605 | $ | 563 | $ | — |
1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
November 30, 2023 |
August 31, 2023 |
December 1, 2022 |
|||||||||
GAAP gross margin | $ | (35) | $ | (435) | $ | 893 | |||||
Stock-based compensation | 67 | 64 | 36 | ||||||||
Other | 5 | 5 | 5 | ||||||||
Non-GAAP gross margin | $ | 37 | $ | (366) | $ | 934 | |||||
GAAP operating expenses | $ | 1,093 | $ | 1,037 | $ | 1,102 | |||||
Stock-based compensation | (115) | (87) | (90) | ||||||||
Restructure and asset impairments | — | (4) | (13) | ||||||||
Goodwill impairment |
— | (101) | — | ||||||||
Other | 14 | (3) | — | ||||||||
Non-GAAP operating expenses | $ | 992 | $ | 842 | $ | 999 | |||||
GAAP operating income (loss) | $ | (1,128) | $ | (1,472) | $ | (209) | |||||
Stock-based compensation | 182 | 151 | 126 | ||||||||
Restructure and asset impairments | — | 4 | 13 | ||||||||
Goodwill impairment |
— | 101 | — | ||||||||
Other | (9) | 8 | 5 | ||||||||
Non-GAAP operating income (loss) | $ | (955) | $ | (1,208) | $ | (65) | |||||
GAAP net income (loss) |
$ | (1,234) | $ | (1,430) | $ | (195) | |||||
Stock-based compensation | 182 | 151 | 126 | ||||||||
Restructure and asset impairments | — | 4 | 13 | ||||||||
Goodwill impairment |
— | 101 | — | ||||||||
Other | (10) | 7 | 10 | ||||||||
Estimated tax effects of above and other tax adjustments |
14 | (10) | 7 | ||||||||
Non-GAAP net income (loss) | $ | (1,048) | $ | (1,177) | $ | (39) | |||||
GAAP diluted earnings (loss) per share |
$ | (1.12) | $ | (1.31) | $ | (0.18) | |||||
Effects of the above adjustments |
0.17 | 0.24 | 0.14 | ||||||||
Non-GAAP diluted earnings (loss) per share |
$ | (0.95) | $ | (1.07) | $ | (0.04) |
1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
November 30, 2023 |
August 31, 2023 |
December 1, 2022 |
|||||||||
GAAP net cash provided by operating activities |
$ | 1,401 | $ | 249 | $ | 943 | |||||
Expenditures for property, plant, and equipment |
(1,796) | (1,461) | (2,449) | ||||||||
Payments on equipment purchase contracts |
(56) | (26) | (47) | ||||||||
Proceeds from sales of property, plant, and equipment | 33 | 18 | 23 | ||||||||
Proceeds from government incentives |
85 | 462 | 2 | ||||||||
Investments in capital expenditures, net | (1,734) | (1,007) | (2,471) | ||||||||
Adjusted free cash flow |
$ | (333) | $ | (758) | $ | (1,528) |
FQ2-24 |
GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue |
$5.30 billion ± $200 million |
— | $5.30 billion ± $200 million |
||||||||||||||||||||
Gross margin |
12.0% ± 1.5% |
1.0% |
A | 13.0% ± 1.5% |
|||||||||||||||||||
Operating expenses |
$1.07 billion ± $15 million |
$122 million |
B | $950 million ± $15 million |
|||||||||||||||||||
Diluted earnings (loss) per share(1) |
($0.45) ± $0.07 |
$0.17 |
A, B, C | ($0.28) ± $0.07 |
Non-GAAP Adjustments
(in millions)
|
|||||||||||||||||||||||
A |
Stock-based compensation – cost of goods sold |
$ | 75 | ||||||||||||||||||||
A |
Other – cost of goods sold |
4 | |||||||||||||||||||||
B |
Stock-based compensation – research and development |
77 | |||||||||||||||||||||
B |
Stock-based compensation – sales, general, and administrative |
45 | |||||||||||||||||||||
C |
Tax effects of the above items and other tax adjustments | (13) | |||||||||||||||||||||
$ | 188 |